Prostate cancer screening : what we know and what we need to know.
To critically evaluate the evidence for recommending the screening of asymptomatic men for prostate cancer with a blood test to detect a prostatespecific antigen (PSA).
Relevant articles on screening for prostate cancer were identified from MEDLINE searches, from the authors'files, and from the bibliographies of identified articles.
In the absence of controlled prospective trials, the studies are primarily retrospective and contain information about the sensitivity, specificity, and predictive values of tests used to screen for prostate cancer; the natural history of untreated prostate cancer, the morbidity, mortality, and costs of definitive treatment; and reviews of screening study biases.
Mots-clés Pascal : Tumeur maligne, Prostate, Homme, Evaluation performance, Dépistage, Pronostic, Mortalité, Randomisation, Prévention, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Malignant tumor, Prostate, Human, Performance evaluation, Medical screening, Prognosis, Mortality, Randomization, Prevention, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0026682
Code Inist : 002B30A01C. Création : 199406.